Biohacking Social Media and Updates

Breakthrough Therapies Extend Survival, Renew Hope for Terminal Illnesses

For those of you who have a terminal illness, a chronic condition, or debilitating health issue, there is new reason to have hope. New treatments are arriving that buy more time for the next to arrive. Even for the most vicious of diseases, for example, metastatic pancreatic cancer. The recent breakthrough, daraxonrasib, nearly doubled overall survival, 6.7 to 13.2 months, with fewer side effects than chemo. It's hard to overstate the significance of this. In a slow world, a few months doesn't matter much. In a fast world, that could mean the difference to make it to the next life-extending therapy. We are on a long arc of getting increasingly better at solving disease. In 1919, Elizabeth Hughes was diagnosed with type 1 diabetes. The only treatment was a starvation diet, which she did for three years. Her weight dropped to 45 pounds at age 14. Then insulin arrived in 1922. It allowed her to live to 73. And recently, Sid Sijbrandij used AI and existing biotech infrastructure to fight a recurring osteosarcoma that standard medicine had given up on. Today he has no evidence of disease. A new era for life is here. It won't appear overnight. Nor will it be all sunshine and rainbows. But we are at the inflection point where hope can dare rise as the sun for those who have been stuck in the darkness.